MRP ₹2834.5
(Inclusive of all Taxes)
₹340.1 Cashback (12%)
Extra 15% Off with Bank Offers
Composition :
DULAGLUTIDE-0.75MG
Manufacturer/Marketer :
Lupin Ltd
Consume Type :
Parenteral
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
_0.jpg?tr=q-85,f-webp,w-100,dpr-1,c-at_max "Santoshini Reddy G")
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
Severe
DulaglutideBexarotene
Severe
Drug-Drug Interactions
Login/Sign Up
Severe
How does the drug interact with Aplevant 0.75 mg Injection:
Co-administration of Aplevant 0.75 mg Injection with Gatifloxacin may increase the risk or severity of low blood sugar.
How to manage the interaction:
Although there is a possible interaction between Aplevant 0.75 mg Injection and Gatifloxacin, you can take these medicines together if prescribed by a doctor. However, if you experience sweating, headache, shortness of breath, or palpitations, contact a doctor immediately. Do not discontinue any medication without a doctor's advice.
Co-administration of Aplevant 0.75 mg Injection with Gatifloxacin may increase the risk or severity of low blood sugar.
How to manage the interaction:
Although there is a possible interaction between Aplevant 0.75 mg Injection and Gatifloxacin, you can take these medicines together if prescribed by a doctor. However, if you experience sweating, headache, shortness of breath, or palpitations, contact a doctor immediately. Do not discontinue any medication without a doctor's advice.
DulaglutideBexarotene
Severe
How does the drug interact with Aplevant 0.75 mg Injection:
Co-administration of Aplevant 0.75 mg Injection with Bexarotene may increase the risk of side effects.
How to manage the interaction:
Although there is a possible interaction between Aplevant 0.75 mg Injection and Bexarotene, you can take these medicines together if prescribed by a doctor. If you're having symptoms like vomiting, stomach pain, or vomiting, contact a doctor right away. Do not stop using any medications without talking to a doctor.
Co-administration of Aplevant 0.75 mg Injection with Bexarotene may increase the risk of side effects.
How to manage the interaction:
Although there is a possible interaction between Aplevant 0.75 mg Injection and Bexarotene, you can take these medicines together if prescribed by a doctor. If you're having symptoms like vomiting, stomach pain, or vomiting, contact a doctor right away. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
DULAGLUTIDE-0.75MGOther diseases of stomach and duodenum
Severe
DULAGLUTIDE-0.75MGAcute pancreatitis
Severe
Drug-Diseases Interactions
Login/Sign Up
DULAGLUTIDE-0.75MGOther diseases of stomach and duodenum
Severe
How does the disease interact with Aplevant 0.75 mg Injection:
Aplevant 0.75 mg Injection delays stomach emptying and has not been investigated in individuals with gastroparesis, therefore it is not indicated in these patients.
How to manage the interaction:
Aplevant 0.75 mg Injection is not recommended in patients with gastroparesis (delayed stomach emptying).
Aplevant 0.75 mg Injection delays stomach emptying and has not been investigated in individuals with gastroparesis, therefore it is not indicated in these patients.
How to manage the interaction:
Aplevant 0.75 mg Injection is not recommended in patients with gastroparesis (delayed stomach emptying).
DULAGLUTIDE-0.75MGAcute pancreatitis
Severe
How does the disease interact with Aplevant 0.75 mg Injection:
The usage of GLP-1 receptor agonists has been associated with a small number of cases of acute pancreatitis. Other diabetes treatments should be examined in individuals with a history of pancreatitis, while it is unclear if they are at higher risk. Patients using GLP-1 receptor agonists should be closely monitored for signs and symptoms of pancreatitis. If this diagnosis is suspected, the therapy should be stopped promptly and appropriate care instituted. If pancreatitis is diagnosed, GLP-1 receptor agonist treatment should be terminated completely.
How to manage the interaction:
Patients receiving treatment with Aplevant 0.75 mg Injection should be carefully observed for signs and symptoms of pancreatitis such as pain in the stomach or back, bloating (belly feels full and tight), nausea, vomiting, indigestion, sweating, fast heart rate, or weight loss. If you notice any of these symptoms, contact your doctor immediately.
The usage of GLP-1 receptor agonists has been associated with a small number of cases of acute pancreatitis. Other diabetes treatments should be examined in individuals with a history of pancreatitis, while it is unclear if they are at higher risk. Patients using GLP-1 receptor agonists should be closely monitored for signs and symptoms of pancreatitis. If this diagnosis is suspected, the therapy should be stopped promptly and appropriate care instituted. If pancreatitis is diagnosed, GLP-1 receptor agonist treatment should be terminated completely.
How to manage the interaction:
Patients receiving treatment with Aplevant 0.75 mg Injection should be carefully observed for signs and symptoms of pancreatitis such as pain in the stomach or back, bloating (belly feels full and tight), nausea, vomiting, indigestion, sweating, fast heart rate, or weight loss. If you notice any of these symptoms, contact your doctor immediately.
DULAGLUTIDE-0.75MGMalignant neoplasm of thyroid gland
Severe
How does the disease interact with Aplevant 0.75 mg Injection:
GLP-1 receptor agonist diabetes medications are not recommended for people who have a personal or family history of medullary thyroid cancer or who have Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
How to manage the interaction:
Aplevant 0.75 mg Injection is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (cancer inside thyroid gland) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (tumors in the thyroid, parathyroid glands, and adrenal glands).
GLP-1 receptor agonist diabetes medications are not recommended for people who have a personal or family history of medullary thyroid cancer or who have Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
How to manage the interaction:
Aplevant 0.75 mg Injection is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (cancer inside thyroid gland) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (tumors in the thyroid, parathyroid glands, and adrenal glands).
All Substitutes & Brand Comparisons
RX
Trulicity 0.75 mg Injection
Eli Lilly and Company (India) Pvt Ltd
₹2834.5
(₹2834.5 per unit)
13% COSTLIER
Have a query?
Customers Also Bought
